| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/21/2008 | WO2008021933A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020495A1 Novel inhibitor |
| 02/21/2008 | WO2008020491A1 Therapeutic agent for pigmented skin lesion |
| 02/21/2008 | WO2008020490A1 Artocarpine derivative or artocarpine-like compound, and hair growth/restoration composition, skin-whitening cosmetic composition, pharmaceutical as anti-cancer, antiphlogistic/analgesic, antipyretic or antiallergic agent and pharmaceutical for treatment of pigmented skin lesion each comprising the same |
| 02/21/2008 | WO2008020119A1 Activated fibroblasts for treating tissue and/or organ damage |
| 02/21/2008 | WO2008020091A1 Pharmaceutical formulation for the treatment of complaints |
| 02/21/2008 | WO2008020030A1 2,5-dihydroxybenzene compounds for the treatment of psoriasis |
| 02/21/2008 | WO2008020028A1 2,5 dihydroxybenzene compounds for the treatment of rosacea |
| 02/21/2008 | WO2008020026A1 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis |
| 02/21/2008 | WO2008020025A1 Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis |
| 02/21/2008 | WO2008019823A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/21/2008 | WO2008001240A3 Transdermal delivery of oleocanthal for relief of inflammation |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | WO2007010294A8 Use of delmopinol in the treatment of acne |
| 02/21/2008 | WO2006032091A3 Herbal composition |
| 02/21/2008 | US20080045709 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/21/2008 | US20080045604 Composition and method for facilitating the healing of non-healing and slow-healing wounds and ulcerations |
| 02/21/2008 | US20080045596 Ep2 Receptor Agonists |
| 02/21/2008 | US20080045594 Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation |
| 02/21/2008 | US20080045549 Adenosine a2b receptor antagonists |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2008 | US20080045479 Compositions and methods for regulating mammalian keratinous tissue |
| 02/21/2008 | US20080045478 For skin/hair light protection; cosmetics |
| 02/21/2008 | US20080045467 Composition Containing Ginsenoside F1 Or Compound K For Skin External Application |
| 02/21/2008 | US20080045465 Phosphole Derivatives Complexed with Metals, and Pharmaceutical Uses Thereof |
| 02/21/2008 | US20080045460 Treatment of prostate cancer by inhibiting lyn-tyrosine kinase |
| 02/21/2008 | US20080044502 Use of an aqueous or hydroalcoholic extract of bauhinia for the preparation of a composition |
| 02/21/2008 | US20080044497 Methods and Pharmaceutical Compositions Useful for Treating Psoriasis |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044439 Compositions and Methods for Preventing and Treating Skin and Hair Conditions |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044423 Compounds |
| 02/21/2008 | US20080044419 Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 |
| 02/21/2008 | US20080044401 Drug therapy for celiac sprue |
| 02/21/2008 | US20080044370 Composition For Scalp And Hair Of Scalp |
| 02/21/2008 | US20080044364 Flavonoid Complexes |
| 02/21/2008 | US20080042818 Trailer tire alert system |
| 02/21/2008 | DE202007015418U1 Präparat auf der Basis von Murmeltierfett mit verschiedenen ätherischen Ölen Preparation on the basis of fat marmot with various essential oils |
| 02/21/2008 | DE202007015417U1 Präparat zur Bekämpfung von Herpes labialis, Herpes vaginalis, Psoriasis, Schmerzen von Verbrennungen 1.ten und 2.ten Grades, infizierten Hautpartien und Neurodermitis 1.ten preparation to combat herpes labialis, herpes vaginalis, psoriasis, pain from burns and 2.ten degree, infected skin and eczema |
| 02/21/2008 | CA2661064A1 Pharmaceutical formula for treating skin disease |
| 02/21/2008 | CA2660903A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660308A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/20/2008 | EP1889850A1 Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| 02/20/2008 | EP1889632A1 Remedy for xanthoma |
| 02/20/2008 | EP1889623A2 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 02/20/2008 | EP1889622A1 Spiropiperidine compound and medicinal use thereof |
| 02/20/2008 | EP1889609A2 Immune response modifier foam formulations |
| 02/20/2008 | EP1889594A2 Aqueous cataplasms containing watercress extract |
| 02/20/2008 | EP1888584A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 02/20/2008 | EP1888527A1 Piperidines for the treatment of chemokine mediated diseases |
| 02/20/2008 | EP1888526A1 Piperidines for the treatment of chemokine mediated diseases |
| 02/20/2008 | EP1887967A2 Dermal fillers for biomedical applications in mammals and methods of using the same |
| 02/20/2008 | EP1575600B1 Cosmetic preparations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride |
| 02/20/2008 | EP1572211B1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 02/20/2008 | EP1451242B1 Water-in-silicone emulsions |
| 02/20/2008 | EP1443964B1 Photodynamic therapy for the treatment of hair loss |
| 02/20/2008 | EP1408966B1 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1131290B1 Piperidine ccr-3 receptor antagonists |
| 02/20/2008 | CN101128452A Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same |
| 02/20/2008 | CN101128208A Formulations and treatments for trichology |
| 02/20/2008 | CN101128193A Anti-radical agents |
| 02/20/2008 | CN101126079A Storage method for melanin cell suspension |
| 02/20/2008 | CN101125179A Wound-healing muscle-growing ointment and production method thereof |
| 02/20/2008 | CN101125176A Medicine for curing psoriasis |
| 02/20/2008 | CN101125161A Burn cream for treating burn and scald and its preparation method |
| 02/20/2008 | CN101125155A Application of erigeron breviscapus methanol extracts in skin-whitening and speckle eliminating prevention |
| 02/20/2008 | CN101125145A Local using prostaglandin micro emulsion and its preparation method |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369914C 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369631C Ultraviolet resistant formulation obtained from cell engineering technology |
| 02/20/2008 | CN100369630C Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 02/20/2008 | CN100369628C Trauma treating drug |
| 02/20/2008 | CN100369617C Chinese medicine composition and its application in health pillow and health pillow |
| 02/20/2008 | CN100369612C External-use powder medicine for wetting burn and empyrosis and its preparing method |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332156 Methods of treating wounds using IL-23 |
| 02/19/2008 | US7332155 comprising comb copolymers based on acryloyldimethyltaurine |
| 02/19/2008 | CA2436572C Perylenequinones for use as photosensitizers and sonosensitizers |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2277207C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |